Axent Biosciences develops next generation stem cell therapies to address unmet medical needs in human health. Spun out of Prof. David Schaffer's Lab at UC Berkeley, Axent's platform technologies in stem cell manufacturing and implantation leverage 20+ years of stem cell expertise and 10+ years of biomaterials engineering to overcome major bottlenecks in the clinical development pipeline to efficiently provide high quality stem cell therapeutics to large populations of patients in need.